Synergistic anti-tumour activity of sorafenib in combination with pegylated resveratrol is mediated by Akt/mTOR/p70S6k-4EBP-1 and c-Raf7MEK/ERK signaling pathways

INTRODUCTION: To investigate the inhibitory effect of sorafenib combined with PEGylated resveratrol on renal cell carcinoma (RCC) and its potential mechanism. METHODS: MTT assay was used to detect the inhibitory effects of PEGylated resveratrol and sorafenib alone or combination on proliferation of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ligang, Wu, Hao, Wang, Ying, Xu, Songcheng, Yang, Chen, Zhang, Tingting, Liu, Yang, Wang, Fuwei, Chen, Weinan, Li, Jianchun, Sun, Litao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470186/
https://www.ncbi.nlm.nih.gov/pubmed/37664741
http://dx.doi.org/10.1016/j.heliyon.2023.e19154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470186/
https://www.ncbi.nlm.nih.gov/pubmed/37664741
http://dx.doi.org/10.1016/j.heliyon.2023.e19154

Ejemplares similares